Verition Fund Management
OSIR

Verition Fund Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Verition Fund Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,440
Closed -$236K – 1552
2019
Q1 		$236K Buy
+12,440
New +$202K 0.01% 922

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Verition Fund Management's OSIR Position: Q2 2019 in Review

Verition Fund Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 12,440 shares — an estimated $236K sold.

Verition Fund Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $236K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Verition Fund Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Verition Fund Management sold 12,440 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $236K.
  • Verition Fund Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Verition Fund Management's Osiris Therapeutics, Inc. Common Stock position peaked at $236K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Verition Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.